RESUMEN
BACKGROUND: Anti-desmoglein (Dsg)1 is produced in pemphigus foliaceus (PF), affecting exclusively the skin. Pemphigus vulgaris (PV) shows the production of anti-Dsg3 in the mucosal form, and anti-Dsg1 and 3 in the mucocutaneous form. Anti-Dsg3 autoantibodies have been rarely reported in PF. OBJECTIVES: To determine the factors associated with the production and pathogenicity of anti-Dsg3 in PF. METHODS: Comparative analytical study of three patients groups: 16 PF-anti-Dsg3+, and 42 PF-anti-Dsg3(-) and 22 PV treatment-naïve cases. Serum was used in the anti-Dsg1 and 3 ELISA, and in immunoblotting (IB) with human epidermis extract. The expression of Dsg1 and 3 in paraffin sections was analyzed by immunohistochemistry (IHC). HLA-DRB1 alleles were compiled from a database. RESULTS: In the PF-anti-Dsg3+ group: age range similar to that of the PV group (pâ¯>â¯0.9999); predominance of the generalized form of PF (pâ¯=â¯0.002); anti-Dsg3 titers lower than those of PV (pâ¯<â¯0.0001); IB confirmed Dsg3 identification in one (8.33%) of 12 patients; IHC showed exclusive cytoplasmic internalization of Dsg1; HLA-DRB1 alleles of susceptibility to PF, with the absence of alleles associated with PV, in the five typed patients. STUDY LIMITATIONS: Most of the patients in the PF-anti-Dsg3+ group were undergoing treatment. CONCLUSION: The presence of anti-Dsg3 antibodies in PF was related to older age (comparable to that of PV) and the generalized form of PF. The non-pathogenicity of anti-Dsg3 antibodies in PF can be attributed to the low serum anti-Dsg3 titers, the lack of Dsg3 internalization as detected by IHC, and the absence of PV-associated HLA-DRB1 alleles.
Asunto(s)
Autoanticuerpos , Desmogleína 1 , Desmogleína 3 , Inmunohistoquímica , Pénfigo , Humanos , Pénfigo/inmunología , Desmogleína 3/inmunología , Autoanticuerpos/inmunología , Autoanticuerpos/sangre , Femenino , Masculino , Persona de Mediana Edad , Adulto , Anciano , Desmogleína 1/inmunología , Ensayo de Inmunoadsorción Enzimática , Adulto Joven , Immunoblotting , Cadenas HLA-DRB1/genética , Cadenas HLA-DRB1/inmunología , Anciano de 80 o más Años , AdolescenteRESUMEN
Abstract Background: Bullous pemphigoid (BP) associated with milia lesions has been increasingly reported, but its prevalence has not been reported in a Brazilian BP population yet. Objectives: To describe the occurrence and clinical-laboratorial findings of BP-milia association in a southeastern Brazilian sample. Methods: A descriptive study based on the medical charts of 102 BP patients was accomplished. Clinical and laboratory data of BP-milia patients were compiled. Total serum IgE measurements, immunoblot assays based on basement membrane zone antigens, and HLA-DQ alleles typing were performed. Results: Milia was evident in 8 (7.8%) BP patients, five males, aged between 46 and 88 years. Increased total IgE levels were determined in 7 (87.5%) of the eight patients. In five of eight patients, immunoblotting showed IgG reactivity against the BP180-NC16a domain but not against collagen VII or laminin-332; it also revealed reactivity against the BP180 C-terminal domain or LAD-1, or both in four of them. The HLA-DQB1*03:01 and HLA-DQA1*05:05 alleles were identified in three of five BP-milia patients. Moreover, three of five cases presented the HLA-DQB1*06 allelic group. Study limitations: HLA determination was performed in five patients. Conclusions: Milia formation in BP patients seems to be less uncommon than previously admitted. Laboratory data revealed increased IgE; autoantibodies against the BP180 C-terminal domain or LAD-1, or both; and the HLA-DQB1*06 allelic group, described for the BP-milia association. Careful determination of antibodies against basement membrane zone molecules and HLA characterization in different populations may provide further insights into this association. © 2022 Sociedade Brasileira de Dermatologia. Published by Elsevier España, S.L.U. This is an open access article under the CC BY license (https://creativecommons.org/licenses/by/4.0/).
RESUMEN
BACKGROUND: Bullous pemphigoid (BP) associated with milia lesions has been increasingly reported, but its prevalence has not been reported in a Brazilian BP population yet. OBJECTIVES: To describe the occurrence and clinical-laboratorial findings of BP-milia association in a southeastern Brazilian sample. METHODS: A descriptive study based on the medical charts of 102 BP patients was accomplished. Clinical and laboratory data of BP-milia patients were compiled. Total serum IgE measurements, immunoblot assays based on basement membrane zone antigens, and HLA-DQ alleles typing were performed. RESULTS: Milia was evident in 8 (7.8%) BP patients, five males, aged between 46 and 88 years. Increased total IgE levels were determined in 7 (87.5%) of the eight patients. In five of eight patients, immunoblotting showed IgG reactivity against the BP180-NC16a domain but not against collagen VII or laminin-332; it also revealed reactivity against the BP180 C-terminal domain or LAD-1, or both in four of them. The HLA-DQB1*03:01 and HLA-DQA1*05:05 alleles were identified in three of five BP-milia patients. Moreover, three of five cases presented the HLA-DQB1*06 allelic group. STUDY LIMITATIONS: HLA determination was performed in five patients. CONCLUSIONS: Milia formation in BP patients seems to be less uncommon than previously admitted. Laboratory data revealed increased IgE; autoantibodies against the BP180 C-terminal domain or LAD-1, or both; and the HLA-DQB1*06 allelic group, described for the BP-milia association. Careful determination of antibodies against basement membrane zone molecules and HLA characterization in different populations may provide further insights into this association.
Asunto(s)
Queratosis , Penfigoide Ampolloso , Anciano , Anciano de 80 o más Años , Autoanticuerpos , Autoantígenos , Brasil , Humanos , Inmunoglobulina E , Queratosis/patología , Laboratorios Clínicos , Masculino , Persona de Mediana Edad , Colágenos no Fibrilares , Penfigoide Ampolloso/patología , PrevalenciaRESUMEN
Localized cutaneous leishmaniasis (LCL) can ultimately progress to chronic ulcerated lesions with strong local inflammatory reactions. The functional role of certain inflammasomes in mediating inflammation caused by Leishmania braziliensis needs to be addressed. By combining PCR-array, quantitative real-time PCR and immunohistochemical analysis, we identified inflammasome genes, such as IL-1ß, NLRP3, NLRP1, NLRC5, AIM2 and P2RX7, that were upregulated in LCL patients. Temporal gene expression studies showed that the early phase of LCL displayed increased NLRP3 and reduced AIM2 and NLRP1 expression, while the late stages showed increased AIM2 and NLRP1 and lower NLRP3 expression. Our findings also showed that AIM2, NLRP1, and P2RX7 promoted susceptibility to experimental L. braziliensis infection. These results highlight the importance of inflammasome machinery in human LCL and suggest that inflammasome machinery plays a role in the acute and chronic phases of the disease.
Asunto(s)
Proteínas Adaptadoras Transductoras de Señales/genética , Proteínas Reguladoras de la Apoptosis/genética , Proteínas de Unión al ADN/genética , Inflamasomas/genética , Leishmaniasis Cutánea/genética , Receptores Purinérgicos P2X7/genética , Piel/inmunología , Proteínas Adaptadoras Transductoras de Señales/inmunología , Adulto , Animales , Proteínas Reguladoras de la Apoptosis/inmunología , Proteínas de Unión al ADN/inmunología , Progresión de la Enfermedad , Susceptibilidad a Enfermedades , Femenino , Perfilación de la Expresión Génica , Regulación de la Expresión Génica , Humanos , Inflamasomas/inmunología , Interleucina-1beta/genética , Interleucina-1beta/inmunología , Péptidos y Proteínas de Señalización Intracelular/genética , Péptidos y Proteínas de Señalización Intracelular/inmunología , Leishmania braziliensis/inmunología , Leishmania braziliensis/patogenicidad , Leishmaniasis Cutánea/inmunología , Leishmaniasis Cutánea/parasitología , Leishmaniasis Cutánea/patología , Masculino , Ratones Endogámicos C57BL , Ratones Noqueados , Proteína con Dominio Pirina 3 de la Familia NLR/genética , Proteína con Dominio Pirina 3 de la Familia NLR/inmunología , Proteínas NLR , Receptores Purinérgicos P2X7/inmunología , Transducción de Señal , Piel/parasitología , Piel/patologíaRESUMEN
Bullous pemphigoid (BP) has been associated with neurological disorders (NDs), which has led to the hypothesis that molecular mimicry exists between hemidesmosomal proteins and neuronal peptides. A 79-year-old hemiparetic woman presented with tense bullae affecting exclusively her right paretic upper limb for three months. Histopathology, taken from the perilesional area, revealed an inflammatory infiltrate with predominant eosinophils. IIF evidenced linear IgG deposition in the epidermal side of the cleavage. ELISA detected circulating anti-BP180 and anti-BP230 autoantibodies. Immunoblotting exhibited unspecific reactivity against the 190-kDa periplakin in normal human epidermal extract. The immunocompromised cutaneous district concept may explain the possible mechanism for the exclusive involvement of the autoimmune blistering disease in lymphedematous hemiparetic upper limb.
Asunto(s)
Isquemia Encefálica/complicaciones , Demencia/complicaciones , Paresia/complicaciones , Penfigoide Ampolloso/diagnóstico , Penfigoide Ampolloso/etiología , Accidente Cerebrovascular/complicaciones , Anciano , Brazo , Humanos , MasculinoAsunto(s)
Autoanticuerpos/sangre , Autoantígenos/inmunología , Desmogleína 1/inmunología , Desmogleína 3/inmunología , Distonina/inmunología , Colágenos no Fibrilares/inmunología , Penfigoide Ampolloso/sangre , Autoanticuerpos/metabolismo , Ensayo de Inmunoadsorción Enzimática , Humanos , Immunoblotting , Inmunoglobulina G/metabolismo , Penfigoide Ampolloso/metabolismo , Colágeno Tipo XVIIRESUMEN
Background: Antibodies against Leishmania peptides (Lbr-peps) and desmogleins (Dsgs) have been reported in pemphigus foliaceus (PF) and leishmaniasis patients, respectively. We aimed to compare serological and genetic features in a Brazilian region endemic for American tegumentary leishmaniasis (ATL) and pemphigus. Methods: Commercial anti-Dsg ELISA and in-house ELISA with Lbr-peps were used to determine the serological profile, in addition to immunoblotting (IB) and indirect immunofluorescence (IIF) assays. HLA-DRB1 and -DQA1/DQB1 alleles were characterized by PCR combined with sequence-specific oligonucleotide probes (PCR-SSOP). The serological and genetic profiles were compared using 78 PF, 62 pemphigus vulgaris (PV) and 58 ATL patients against 163 and 1592 healthy controls, respectively. Results: Some ATL patients showed positive results for anti-Dsg1 and/or anti-Dsg3 antibodies. They also revealed 130, 160 and/or 230 kDa epidermal peptides in IB. Moreover, some ATL samples exhibited pemphigus or a bullous pemphigoid pattern in IIF. ELISA and IB assays showed Lbr-peps in pemphigus patients. HLA-DQA1*01 and -DQA1*01:02 were protective and susceptibility alleles for ATL, respectively, but the opposite for pemphigus. Conclusions: Anti-Dsgs in ATL may represent epiphenomena. Anti-Lbr-pep antibodies in pemphigus suggest a previous infection. A differential association of the HLA profile may contribute to the lack of co-association between pemphigus and ATL.
Asunto(s)
Desmogleínas/sangre , Leishmaniasis Cutánea/diagnóstico , Pénfigo/diagnóstico , Adulto , Alelos , Brasil/epidemiología , Ensayo de Inmunoadsorción Enzimática , Femenino , Interacción Gen-Ambiente , Predisposición Genética a la Enfermedad , Cadenas beta de HLA-DQ/sangre , Cadenas HLA-DRB1/sangre , Humanos , Immunoblotting , Leishmaniasis Cutánea/genética , Masculino , Persona de Mediana Edad , Pénfigo/genéticaRESUMEN
Pemphigus vulgaris (PV) and pemphigus foliaceus (PF) are blistering autoimmune diseases that depend on interaction between genetic and environmental factors. Viral infections, like herpes simplex viruses 1 and 2 (HSV1/2), cytomegalovirus (CMV), Epstein-Barr virus and dengue virus, could trigger or exacerbate pemphigus. IgM and IgG antibodies against these viruses in serum from PV and PF, their relatives and controls were determined. HSV1/2 expression was evaluated by direct immunofluorescence (DIF) and qPCR in affected or not oral mucosa from PV patients compared with uninjured PF mucosa. IgG anti-HSV1 was higher in the PV group compared with all groups. IgG anti-CMV resulted higher in PV group compared with PF patients and PV relatives. HSV1 was confirmed by DIF and qPCR on oral samples from patients with PV. Lack of HSV1 expression in the oral mucosa of patients with PF corroborate that immunosuppressive therapy cannot be the main cause for HSV1 replication in PV disease.
Asunto(s)
Citomegalovirus/inmunología , Herpesvirus Humano 1/inmunología , Inmunoglobulina G/sangre , Inmunoglobulina M/sangre , Pénfigo/sangre , Estudios de Casos y Controles , Infecciones por Citomegalovirus/sangre , Herpes Simple/sangre , Herpesvirus Humano 1/genética , Herpesvirus Humano 2/genética , Herpesvirus Humano 2/inmunología , Humanos , Mucosa Bucal/inmunología , Pénfigo/inmunología , Pénfigo/virologíaRESUMEN
Distinct cases of Paracoccidioidomycosis and Cryptococcosis with atypical and localized skin manifestation on the upper limbs of two elderly patients are reported. In the 2nd one, he presented asymptomatic pulmonary cancer; the blood tests for fungal infection were negative, and the etiologic agents were seen in skin biopsy samples. This report emphasizes the importance of the differential diagnosis of infectious diseases in elderly patients.
Asunto(s)
Criptococosis/patología , Dermatomicosis/patología , Paracoccidioidomicosis/patología , Enfermedades Cutáneas Bacterianas/patología , Anciano , Biopsia , Carcinoma de Células Escamosas/patología , Diagnóstico Diferencial , Resultado Fatal , Femenino , Humanos , Neoplasias Pulmonares/patología , Masculino , Piel/patologíaRESUMEN
Abstract Distinct cases of Paracoccidioidomycosis and Cryptococcosis with atypical and localized skin manifestation on the upper limbs of two elderly patients are reported. In the 2nd one, he presented asymptomatic pulmonary cancer; the blood tests for fungal infection were negative, and the etiologic agents were seen in skin biopsy samples. This report emphasizes the importance of the differential diagnosis of infectious diseases in elderly patients.
Asunto(s)
Humanos , Masculino , Femenino , Anciano , Paracoccidioidomicosis/patología , Enfermedades Cutáneas Bacterianas/patología , Criptococosis/patología , Dermatomicosis/patología , Piel/patología , Biopsia , Carcinoma de Células Escamosas/patología , Resultado Fatal , Diagnóstico Diferencial , Neoplasias Pulmonares/patologíaRESUMEN
Fluoxetine (FLX) is a drug commonly used as antidepressant. However, its effects on tumorigenesis remain controversial. Aiming to evaluate the effects of FLX treatment on early malignant changes, we analyzed serotonin (5-HT) metabolism and recognition, aberrant crypt foci (ACF), proliferative process, microvessels, vascular endothelial growth factor (VEGF), and cyclooxygenase-2 (COX-2) expression in colon tissue. Male Wistar rats received a daily FLX-gavage (30mgkg(-1)) and, a single dose of 1,2 dimethylhydrazine (DMH; i.p., 125mgkg(-1)). After 6 weeks of FLX-treatment, our results revealed that FLX and nor-fluoxetine (N-FLX) are present in colon tissue, which was related to significant increase in serotonin (5-HT) levels (P<0.05) possibly through a blockade in SERT mRNA (serotonin reuptake transporter; P<0.05) resulting in lower 5-hydroxyindoleacetic acid (5-HIAA) levels (P<0.01) and, 5-HT2C receptor mRNA expressions. FLX-treatment decreased dysplastic ACF development (P<0.01) and proliferative process (P<0.001) in epithelia. We observed a significant decrease in the development of malignant microvessels (P<0.05), VEGF (P<0.001), and COX-2 expression (P<0.01). These findings suggest that FLX may have oncostatic effects on carcinogenic colon tissue, probably due to its modulatory activity on 5-HT metabolism and/or its ability to reduce colonic malignant events.
Asunto(s)
Neoplasias del Colon/prevención & control , Fluoxetina/farmacología , Inhibidores Selectivos de la Recaptación de Serotonina/farmacología , Animales , Proliferación Celular , Colon/efectos de los fármacos , Colon/metabolismo , Ciclooxigenasa 2/análisis , Masculino , Lesiones Precancerosas/prevención & control , Ratas , Ratas Wistar , Serotonina/metabolismo , Factor A de Crecimiento Endotelial Vascular/análisisRESUMEN
Aberrant crypt foci (ACF) and colon rectal mucosal epithelial cell proliferation have been shown to be increased in patients with colon cancer and have been largely used for early detection of factors that influence colorectal carcinogenesis in rats. Fifty male Wistar rats were randomly divided into 5 groups. The groups G1 to G4 were given 4 injections of the carcinogen 1,2-dimethylhydrazine (DMH). The G2 group received Lychnophora ericoides (LE) extracts for 6 wk. The groups G3 and G4 received LE for 4 wk and 2 wk, respectively, at the postinitiation and initiation phases of colonic carcinogenesis. The group G5 was the control. Forty-two days after the first injections of DMH for the neoplasic induction, we observed a statistically significant decrease in the number of aberrant crypt foci (ACF) and an attenuation of the increase in cell proliferation induced by DMH in all the LE-treated groups. Thus, we concluded that Lychnophora ericoides extracts were effective against the development of cancer. These data suggest that LE has a protective influence on the process of colon carcinogenesis, suppressing both the initiation and the promotion of colonic carcinogenesis.
Asunto(s)
Focos de Criptas Aberrantes/tratamiento farmacológico , Anticarcinógenos/farmacología , Fitoterapia , Extractos Vegetales/farmacología , Lesiones Precancerosas , 1,2-Dimetilhidrazina/toxicidad , Focos de Criptas Aberrantes/inducido químicamente , Animales , Antiinflamatorios no Esteroideos/farmacología , Arnica/química , Carcinógenos/toxicidad , Proliferación Celular , Cromatografía Líquida de Alta Presión , Neoplasias del Colon/inducido químicamente , Neoplasias del Colon/tratamiento farmacológico , Ciclooxigenasa 2/genética , Ciclooxigenasa 2/metabolismo , Mucosa Intestinal , Masculino , Neoplasias Experimentales/inducido químicamente , Neoplasias Experimentales/tratamiento farmacológico , Ratas , Ratas WistarRESUMEN
INTRODUCTION: stem cells may originate and perpetuate the tumor growth, but they are poorly known in gliomagenesis. Metallothioneins (MTs) are proteins involved in oncogenesis and immunopositivity, for MT may be used as a stem cell mutation marker. OBJECTIVE: to study the MT expression in the ENU experimental model and to establish an experimental model to track glioma stem cells in early oncogenesis. METHODS: Thirty-six male Wistar rats were divided into two groups; the experimental group was treated within 24 hours after birth (neonate rats) with a single dose of subcutaneously injected N-ethyl N-nitrosourea ENU (40 mg/kg body weight). The control animals were injected with the same volume of saline. These experimental animals were subdivided into three groups according to the euthanize time, as follows: the Group 1 (G1) was euthanized at the age of 30 days; the Group 2 (G2), at the age of 180 days and the Group 3 (G3) was euthanized soon after the appearing of signs of the existence of nervous system tumors, at an average age of 321 days. Immunohistochemical detection of MT protein in cold acetone-fixed paraffin embedded spine cord sections was performed by the streptavidin-avidin-biotin-immuno peroxidase complex method. RESULTS: by using the experimental model of gliomagenesis induced by the N-ethyl N-nitrosourea, it was possible to detect putative tumor stem cells in early oncogenesis, to analyze a field cancerization process and to observe a close morphological relationship between MT positive cells and blood vessels. CONCLUSIONS: this reproducible experimental model allows further studies on the origins, development and regulating factors involved in gliomagenesis.
INTRODUÇÃO: células-tronco podem originar e perpetuar o crescimento tumoral, porém são pouco conhecidas na gliomagênese. As metalotioneínas (MTs) são proteínas envolvidas na oncogênese, e sua a imunopositividade pode ser utilizada como marcador de mutação de células-tronco. Objetivo: estudar a expressão de MT no modelo experimental da ENU e estabelecer um modelo experimental para monitorar as células-tronco glioma na oncogênese. MÉTODOS: Trinta e seis ratos machos da raça Wistar foram divididos em dois grupos; o grupo de animais experimental foi tratado dentro de 24 horas após o nascimento (ratos neonatos) com uma dose única de N-etil N-nitrosoureia (ENU) (40 mg/kg). Nos animais do grupo controle, injetou-se o mesmo volume de solução salina. Os animais do grupo experimental foram subdivididos em três grupos de acordo com o tempo da eutanásia, como se segue: o Grupo 1 (G1) sofreu eutanásia com a idade de 30 dias; o Grupo 2 (G2), com 180 dias e o Grupo 3 (G3) sofreu eutanásia logo após o surgimento de sinais de existência de tumor do sistema nervoso, com uma média de idade de 321 dias. A detecção imunohistoquímica da proteína MT em cortes da medula espinhal fixadas em acetona fria e embebidas em parafina foi realizada pelo método do complexo streptavidina-avidina-biotina-imuno peroxidase. RESULTADOS: por meio de modelos experimentais de gliomagenese induzida pela N-etil N-nitrosoureia, foi possível detectar células-tronco de tumor putativo no início da oncogênese, analisar um processo de cancerização de campo e observar uma relação morfológica entre células positivas para MT e vasos sanguíneos. CONCLUSÕES: este modelo experimental reprodutível permite outros estudos sobre a origem, desenvolvimento e fatores reguladores da gliomatogênese.
INTRODUCCIÓN: células madre pueden originar y perpetuar el crecimiento tumoral, sin embargo son poco conocidas en la gliomagénesis. Las metalotioneínas (MTs) son proteínas involucradas en la oncogénesis, y la inmunopositividad de las MTs puede ser utilizada como marcador de mutación de las células madres. Objetivo: estudio de la expresión de MT en el modelo experimental de la N-etil N-nitrosoureia (ENU) y establecer un modelo experimental para el seguimiento de las células madre en la oncogénesis glioma. MÉTODOS: treinta y seis ratas machos Wistar fueron divididas en dos grupos, un grupo de animales experimentales fue tratado dentro de 24 horas después del nacimiento (ratas neonatas) con una dosis única de ENU (40 mg/kg). Los animales del Grupo Control fueron inyectados con el mismo volumen de solución salina. Los animales del Grupo Experimental fueron subdivididos en tres grupos de acuerdo con el tiempo de eutanasia, así como sigue: el Grupo G1 sufrió eutanasia con la edad de 30 días; el Grupo G2, con 180 días y el Grupo G3, después del surgimiento de señales de existencia de tumor del sistema nervioso, con un promedio de edad de 321 días. La detección inmunohistoquímica de la proteína MT en cortes de médula espinal fijados en acetona fría y embebidos en parafina fue realizada por el método del complejo estreptovidina-avidina-biotina-inmuno peroxidase. RESULTADOS: por medio de modelos experimentales de gliomagénesis inducida por la ENU fue observado que es posible detectar células madre de tumor putativo en el inicio de la oncogénesis, para realizar un proceso de cancerización de campo y observar una relación morfológica entre células positivas para MT y vasos sanguíneos. CONCLUSIÓN: este modelo experimental reproductible permite otros estudios involucrando el origen, desarrollo y factores reguladores de la gliomatogénesis.
Asunto(s)
Animales , Eutanasia Animal , Glioma , Oncología Médica , Metalotioneína , Células MadreRESUMEN
PURPOSES: There is evidence that the risk of colon cancer is reduced by appropriate levels of physical exercise. Nevertheless, the mechanisms involved in this protective effect of exercise remain largely unknown. Inflammation is emerging as a unifying link between a range of environment exposures and neoplastic risk. The carcinogen dimethyl-hydrazine (DMH) induces an increase in epithelial cell proliferation and in the expression of the inflammation-related enzyme cyclooxigenase-2 (COX-2) in the colon of rats. Our aim was to verify whether these events could be attenuated by exercise. METHODS: Four groups of eight Wistar rats were used in the experiment. The groups G1 and G3 were sedentary (controls), and the groups G2 and G4 were submitted to 8 wk of swimming training, 5 d.wk. The groups G3 and G4 were given subcutaneous injections of DMH immediately after the exercise protocols. Fifteen days after the neoplasic induction, the rats were sacrificed and the colon was processed for histological examination and immunohistochemistry staining of proliferating cell nuclear antigen (PCNA) and COX-2. RESULTS: We found a significant increase in the PCNA-labeling index in both DMH-treated groups of rats. However, this increase was significantly attenuated in the training group G4 (P < 0.01). Similar results were observed in relation to the COX-2 expression. CONCLUSIONS: From our findings, we conclude that exercise training exerts remarkable antiproliferative and antiinflammatory effects in the rat colonic mucosa, suggesting that this may be an important mechanism to explain how exercise protects against colonic cancer.
Asunto(s)
Proliferación Celular/efectos de la radiación , Neoplasias del Colon/fisiopatología , Inflamación/fisiopatología , Mucosa Intestinal/fisiopatología , Condicionamiento Físico Animal , Animales , Ciclooxigenasa 2/biosíntesis , Ciclooxigenasa 2/efectos de los fármacos , Dimetilhidrazinas , Inflamación/prevención & control , Interleucina-6/biosíntesis , Mucosa Intestinal/fisiología , Masculino , Ratas , Ratas Wistar , Factores de RiesgoRESUMEN
Orlistat is an anti-obesity agent that increases the fecal fat excretion, which promotes colon carcinogenesis. Therefore, the present study was designed to verify the effects of Orlistat on the formation of rat colonic aberrant crypt foci (ACF) and cell proliferation evaluated by the PCNA method. Male Wistar rats received either a standard diet or a high fat diet (HFD), supplemented or not with Orlistat (200mg/kg chow) and two doses of the carcinogen dimethyl-hydrazine (25mg/Kg). After 30 days, Orlistat was associated to a significant increase in the number of colonic ACFs and cell proliferation in DMH-treated animals, independently of the HFD.